Advertisement

Topics

French Biotech may also save Toddlers from Life-Threatening Peanut Allergy

04:45 EDT 2 Aug 2017 | Labiotech.eu

The first French biotech to NASDAQ, DBV, is expanding the patient group for its promising peanut allergy treatment to include toddlers. DBV‘s Phase IIb results of its peanut allergy therapy, Viaskin Peanut, were one of 2016’s biggest clinical success stories when ...

This awesome article French Biotech may also save Toddlers from Life-Threatening Peanut Allergy appeared first on Labiotech.eu. Be kind and don't copy it without asking ;)

Original Article: French Biotech may also save Toddlers from Life-Threatening Peanut Allergy

NEXT ARTICLE

More From BioPortfolio on "French Biotech may also save Toddlers from Life-Threatening Peanut Allergy"

Quick Search
Advertisement
 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Allergies
The term allergy is used to describe a response, within the body, to a substance, which is not necessarily harmful in itself, but results in an immune response and a reaction that causes symptoms and disease in a predisposed person, which in turn can cau...